| For: | Okuda T, Azuma T, Ohtani M, Masaki R, Ito Y, Yamazaki Y, Ito S, Kuriyama M. Hypoxia-inducible factor 1 alpha and vascular endothelial growth factor overexpression in ischemic colitis. World J Gastroenterol 2005; 11(10): 1535-1539 [PMID: 15770733 DOI: 10.3748/wjg.v11.i10.1535] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v11/i10/1535.htm |
| Number | Citing Articles |
| 1 |
Merja Vakkala, Jouko J Laurila, Juha Saarnio, Vesa Koivukangas, Hannu Syrjälä, Tuomo Karttunen, Ylermi Soini, Tero I Ala-Kokko. Cellular turnover and expression of hypoxic-inducible factor in acute acalculous and calculous cholecystitis. Critical Care 2007; 11(5) doi: 10.1186/cc6170
|
| 2 |
Jihan Harki, Aria Sana, Désirée van Noord, Paul J. van Diest, Petra van der Groep, Ernst J. Kuipers, Leon M. G. Moons, Katharina Biermann, Eric T. T. L. Tjwa. Hypoxia-inducible factor 1-α in chronic gastrointestinal ischemia. Virchows Archiv 2015; 466(2) doi: 10.1007/s00428-014-1691-6
|
| 3 |
Gaëlle Cane, Amandine Ginouvès, Sandrine Marchetti, Roser Buscà, Jacques Pouysségur, Edurne Berra, Paul Hofman, Valérie Vouret-Craviari. HIF-1α mediates the induction of IL-8 and VEGF expression on infection with Afa/Dr diffusely adheringE. coliand promotes EMT-like behaviour. Cellular Microbiology 2010; 12(5) doi: 10.1111/j.1462-5822.2009.01422.x
|
| 4 |
Nancy A. Louis, Kathryn E. Hamilton, Geraldine Canny, Laurie L. Shekels, Samuel B. Ho, Sean P. Colgan. Selective induction of mucin‐3 by hypoxia in intestinal epithelia. Journal of Cellular Biochemistry 2006; 99(6) doi: 10.1002/jcb.20947
|
| 5 |
T. OKUDA, T. AZUMA, M. OHTANI, S. MATSUNAGA, R. MASAKI, S. SATOMI, T. INAGAKI, A. MURAMATSU, S. LEE, H. SUTO, Y. ITO, Y. YAMAZAKI, S. ITO, M. KURIYAMA. Hypoxia‐inducible factor‐1 alpha and vascular endothelial growth factor expression in ischaemic colitis and ulcerative colitis. Alimentary Pharmacology & Therapeutics Symposium Series 2006; 2(1) doi: 10.1111/j.1746-6342.2006.00043.x
|
| 6 |
Monica M. Olcina, Amato J. Giaccia. Reducing radiation-induced gastrointestinal toxicity — the role of the PHD/HIF axis. Journal of Clinical Investigation 2016; 126(10) doi: 10.1172/JCI84432
|
| 7 |
T. OKUDA, T. AZUMA, M. OHTANI, S. MATSUNAGA, R. MASAKI, S. SATOMI, T. INAGAKI, A. MURAMATSU, S. LEE, H. SUTO, Y. ITO, Y. YAMAZAKI, S. ITO, M. KURIYAMA. Hypoxia‐inducible factor‐1 alpha and vascular endothelial growth factor expression in ischaemic colitis and ulcerative colitis. Alimentary Pharmacology & Therapeutics 2006; 24(s4) doi: 10.1111/j.1365-2036.2006.00043.x
|
| 8 |
Dae-Seung Kim, Su-Jin Kim, Min-Cheol Kim, Yong-Deok Jeon, Jae-young Um, Seung-Heon Hong. The Therapeutic Effect of Chelidonic Acid on Ulcerative Colitis. Biological and Pharmaceutical Bulletin 2012; 35(5) doi: 10.1248/bpb.35.666
|
| 9 |
Dolores Ortiz-Masià, Irene Díez, Sara Calatayud, Carlos Hernández, Jesús Cosín-Roger, Joaquín Hinojosa, Juan V. Esplugues, María D. Barrachina, Holger K. Eltzschig. Induction of CD36 and Thrombospondin-1 in Macrophages by Hypoxia-Inducible Factor 1 and Its Relevance in the Inflammatory Process. PLoS ONE 2012; 7(10) doi: 10.1371/journal.pone.0048535
|
| 10 |
Sa-Rang Oh, Seon Ok, Tae-Sung Jung, Sang-Ok Jeon, Ji-Min Park, Ji-wook Jung, Deok-Seon Ryu. Protective effect of decursin and decursinol angelate-rich Angelica gigas Nakai extract on dextran sulfate sodium-induced murine ulcerative colitis. Asian Pacific Journal of Tropical Medicine 2017; 10(9) doi: 10.1016/j.apjtm.2017.08.017
|
| 11 |
Yuehua Chen, Toshiaki Ohara, Yusuke Hamada, Yuze Wang, Miao Tian, Kazuhiro Noma, Hiroshi Tazawa, Masayoshi Fujisawa, Teizo Yoshimura, Akihiro Matsukawa. HIF-PH inhibitors induce pseudohypoxia in T cells and suppress the growth of microsatellite stable colorectal cancer by enhancing antitumor immune responses. Cancer Immunology, Immunotherapy 2025; 74(7) doi: 10.1007/s00262-025-04067-3
|
| 12 |
Sung-Eun Kim, Il-Gyu Ko, Jun-Jang Jin, Lakkyong Hwang, Chang-Ju Kim, Sang-Hoon Kim, Jin-Hee Han, Jung Won Jeon, Anna Chiarini. Polydeoxyribonucleotide Exerts Therapeutic Effect by Increasing VEGF and Inhibiting Inflammatory Cytokines in Ischemic Colitis Rats. BioMed Research International 2020; 2020(1) doi: 10.1155/2020/2169083
|
| 13 |
A H R Varey, E S Rennel, Y Qiu, H S Bevan, R M Perrin, S Raffy, A R Dixon, C Paraskeva, O Zaccheo, A B Hassan, S J Harper, D O Bates. VEGF165b, an antiangiogenic VEGF-A isoform, binds and inhibits bevacizumab treatment in experimental colorectal carcinoma: balance of pro- and antiangiogenic VEGF-A isoforms has implications for therapy. British Journal of Cancer 2008; 98(8) doi: 10.1038/sj.bjc.6604308
|
| 14 |
Dae-Seung Kim, Sung-Hee Kim, Ji-Ye Kee, Yo-Han Han, JinBong Park, Jeong-Geon Mun, Moon-Jung Joo, Yong-Deok Jeon, Su-Jin Kim, Sang-Hyun Park, Sung-Joo Park, Jae-Young Um, Seung-Heon Hong. Eclipta prostrataImproves DSS-Induced Colitis through Regulation of Inflammatory Response in Intestinal Epithelial Cells. The American Journal of Chinese Medicine 2017; 45(05) doi: 10.1142/S0192415X17500562
|
| 15 |
Monica M Olcina, Ryan K Kim, Stavros Melemenidis, Edward E Graves, Amato J Giaccia. The tumour microenvironment links complement system dysregulation and hypoxic signalling. The British Journal of Radiology 2018; 92(1093) doi: 10.1259/bjr.20180069
|
| 16 |
Nels Olson, Albert van der Vliet. Interactions between nitric oxide and hypoxia-inducible factor signaling pathways in inflammatory disease. Nitric Oxide 2011; 25(2) doi: 10.1016/j.niox.2010.12.010
|
| 17 |
Andreas Robinson, Simon Keely, Jörn Karhausen, Mark E. Gerich, Glenn T. Furuta, Sean P. Colgan. Mucosal Protection by Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibition. Gastroenterology 2008; 134(1) doi: 10.1053/j.gastro.2007.09.033
|